Commentary: efficacy and safety of ribavirin plus pegylated interferon‐alpha in geriatric patients with chronic hepatitis C

Saved in:
Bibliographic Details
Published in:Alimentary pharmacology & therapeutics 2013-02, Vol.37 (4), p.491-491
Main Authors: Hadziyannis, S. J., Sevastianos, V.
Format: Article
Language:English
Subjects:
Antiviral Agents - therapeutic use
Female
Hepatitis C, Chronic - drug therapy
Humans
Interferon-alpha - therapeutic use
Male
Polyethylene Glycols - therapeutic use
Recombinant Proteins - therapeutic use
Ribavirin - therapeutic use
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3255-14341b2bcd052edb045bdb695ae6ef47b8674fcaf01f971e847fe2818f43e4103
cites cdi_FETCH-LOGICAL-c3255-14341b2bcd052edb045bdb695ae6ef47b8674fcaf01f971e847fe2818f43e4103
container_end_page 491
container_issue 4
container_start_page 491
container_title Alimentary pharmacology & therapeutics
container_volume 37
creator Hadziyannis, S. J.
Sevastianos, V.
description
doi_str_mv 10.1111/apt.12175
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1273777868</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1273777868</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3255-14341b2bcd052edb045bdb695ae6ef47b8674fcaf01f971e847fe2818f43e4103</originalsourceid><addsrcrecordid>eNp1kMtKAzEYRoMotlYXvoBkqYvRXGaSqTsp3qCgC10PmcyfNjI3k9QyC8FH8Bl9EqNVd2bzw8fhQA5Ch5Sc0vjOVB9OKaMy20JjykWWMMLFNhoTJqYJyykfoT3vnwghQhK2i0aMcy6EzMfoddY1DbRBueEcgzFWKz1g1VbYKwNhwJ3BzpbqxTrb4r5eedzDYqhVgArbNoAz4Lr24-1d1f1SxQkvwFkVnNW4V8FGt8drG5ZYLyMY1yV87cF6PNtHO0bVHg5-7gQ9Xl0-zG6S-d317exinmjOsiyhKU9pyUpdkYxBVZI0K6tSTDMFAkwqy1zI1GhlCDVTSSFPpYH479ykHFJK-AQdb7y9655X4EPRWK-hrlUL3coXlEkupcxFHtGTDapd570DU_TONjFPQUnxVbuItYvv2pE9-tGuygaqP_I3bwTONsDa1jD8byou7h82yk-V5YyD</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1273777868</pqid></control><display><type>article</type><title>Commentary: efficacy and safety of ribavirin plus pegylated interferon‐alpha in geriatric patients with chronic hepatitis C</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Hadziyannis, S. J. ; Sevastianos, V.</creator><creatorcontrib>Hadziyannis, S. J. ; Sevastianos, V.</creatorcontrib><identifier>ISSN: 0269-2813</identifier><identifier>EISSN: 1365-2036</identifier><identifier>DOI: 10.1111/apt.12175</identifier><identifier>PMID: 23336678</identifier><language>eng</language><publisher>England</publisher><subject>Antiviral Agents - therapeutic use ; Female ; Hepatitis C, Chronic - drug therapy ; Humans ; Interferon-alpha - therapeutic use ; Male ; Polyethylene Glycols - therapeutic use ; Recombinant Proteins - therapeutic use ; Ribavirin - therapeutic use</subject><ispartof>Alimentary pharmacology &amp; therapeutics, 2013-02, Vol.37 (4), p.491-491</ispartof><rights>2013 Blackwell Publishing Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3255-14341b2bcd052edb045bdb695ae6ef47b8674fcaf01f971e847fe2818f43e4103</citedby><cites>FETCH-LOGICAL-c3255-14341b2bcd052edb045bdb695ae6ef47b8674fcaf01f971e847fe2818f43e4103</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23336678$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hadziyannis, S. J.</creatorcontrib><creatorcontrib>Sevastianos, V.</creatorcontrib><title>Commentary: efficacy and safety of ribavirin plus pegylated interferon‐alpha in geriatric patients with chronic hepatitis C</title><title>Alimentary pharmacology &amp; therapeutics</title><addtitle>Aliment Pharmacol Ther</addtitle><subject>Antiviral Agents - therapeutic use</subject><subject>Female</subject><subject>Hepatitis C, Chronic - drug therapy</subject><subject>Humans</subject><subject>Interferon-alpha - therapeutic use</subject><subject>Male</subject><subject>Polyethylene Glycols - therapeutic use</subject><subject>Recombinant Proteins - therapeutic use</subject><subject>Ribavirin - therapeutic use</subject><issn>0269-2813</issn><issn>1365-2036</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNp1kMtKAzEYRoMotlYXvoBkqYvRXGaSqTsp3qCgC10PmcyfNjI3k9QyC8FH8Bl9EqNVd2bzw8fhQA5Ch5Sc0vjOVB9OKaMy20JjykWWMMLFNhoTJqYJyykfoT3vnwghQhK2i0aMcy6EzMfoddY1DbRBueEcgzFWKz1g1VbYKwNhwJ3BzpbqxTrb4r5eedzDYqhVgArbNoAz4Lr24-1d1f1SxQkvwFkVnNW4V8FGt8drG5ZYLyMY1yV87cF6PNtHO0bVHg5-7gQ9Xl0-zG6S-d317exinmjOsiyhKU9pyUpdkYxBVZI0K6tSTDMFAkwqy1zI1GhlCDVTSSFPpYH479ykHFJK-AQdb7y9655X4EPRWK-hrlUL3coXlEkupcxFHtGTDapd570DU_TONjFPQUnxVbuItYvv2pE9-tGuygaqP_I3bwTONsDa1jD8byou7h82yk-V5YyD</recordid><startdate>201302</startdate><enddate>201302</enddate><creator>Hadziyannis, S. J.</creator><creator>Sevastianos, V.</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201302</creationdate><title>Commentary: efficacy and safety of ribavirin plus pegylated interferon‐alpha in geriatric patients with chronic hepatitis C</title><author>Hadziyannis, S. J. ; Sevastianos, V.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3255-14341b2bcd052edb045bdb695ae6ef47b8674fcaf01f971e847fe2818f43e4103</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Antiviral Agents - therapeutic use</topic><topic>Female</topic><topic>Hepatitis C, Chronic - drug therapy</topic><topic>Humans</topic><topic>Interferon-alpha - therapeutic use</topic><topic>Male</topic><topic>Polyethylene Glycols - therapeutic use</topic><topic>Recombinant Proteins - therapeutic use</topic><topic>Ribavirin - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hadziyannis, S. J.</creatorcontrib><creatorcontrib>Sevastianos, V.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Alimentary pharmacology &amp; therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hadziyannis, S. J.</au><au>Sevastianos, V.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Commentary: efficacy and safety of ribavirin plus pegylated interferon‐alpha in geriatric patients with chronic hepatitis C</atitle><jtitle>Alimentary pharmacology &amp; therapeutics</jtitle><addtitle>Aliment Pharmacol Ther</addtitle><date>2013-02</date><risdate>2013</risdate><volume>37</volume><issue>4</issue><spage>491</spage><epage>491</epage><pages>491-491</pages><issn>0269-2813</issn><eissn>1365-2036</eissn><cop>England</cop><pmid>23336678</pmid><doi>10.1111/apt.12175</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0269-2813
ispartof Alimentary pharmacology & therapeutics, 2013-02, Vol.37 (4), p.491-491
issn 0269-2813
1365-2036
language eng
recordid cdi_proquest_miscellaneous_1273777868
source Wiley-Blackwell Read & Publish Collection
subjects Antiviral Agents - therapeutic use
Female
Hepatitis C, Chronic - drug therapy
Humans
Interferon-alpha - therapeutic use
Male
Polyethylene Glycols - therapeutic use
Recombinant Proteins - therapeutic use
Ribavirin - therapeutic use
title Commentary: efficacy and safety of ribavirin plus pegylated interferon‐alpha in geriatric patients with chronic hepatitis C
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T03%3A00%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Commentary:%20efficacy%20and%20safety%20of%20ribavirin%20plus%20pegylated%20interferon%E2%80%90alpha%20in%20geriatric%20patients%20with%20chronic%20hepatitis%20C&rft.jtitle=Alimentary%20pharmacology%20&%20therapeutics&rft.au=Hadziyannis,%20S.%20J.&rft.date=2013-02&rft.volume=37&rft.issue=4&rft.spage=491&rft.epage=491&rft.pages=491-491&rft.issn=0269-2813&rft.eissn=1365-2036&rft_id=info:doi/10.1111/apt.12175&rft_dat=%3Cproquest_cross%3E1273777868%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3255-14341b2bcd052edb045bdb695ae6ef47b8674fcaf01f971e847fe2818f43e4103%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1273777868&rft_id=info:pmid/23336678&rfr_iscdi=true